Crystal Adam — SEC Form 4 filings

SEC reporting owner CIK 1825445. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-02-05 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tango Therapeutics, Inc. (TNGX)President, R&D1520 legs · 328,162 sh · $6,477,83622

Form 4 filings — Crystal Adam

FiledFormIssuerReported transactionsSource
2026-09-034Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 27,000 @ $22.37 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-08-054Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 5,267 @ $26.79 · Sale (S): 21,733 @ $27.35 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-07-024Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 19,629 @ $29.34 · Sale (S): 7,371 @ $30.25 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-06-034Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 6,140 @ $22.25 · Sale (S): 20,860 @ $23.06 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-05-054Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 25,900 @ $21.19 · Sale (S): 1,100 @ $22.00 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-04-164Tango Therapeutics, Inc. (TNGX)Option exercise (M): 38,460 @ $5.20 · Sale (S): 38,460 @ $25 · Option exercise (M): 38,460 (derivative) @ $0EDGAR
2026-04-024Tango Therapeutics, Inc. (TNGX)Option exercise (M): 27,000 @ $5.20 · Sale (S): 27,000 @ $21.20 · Option exercise (M): 27,000 (derivative) @ $0EDGAR
2026-03-274Tango Therapeutics, Inc. (TNGX)Option exercise (M): 12,000 @ $5.20 · Sale (S): 12,000 @ $20.11 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2026-03-094Tango Therapeutics, Inc. (TNGX)Sale (S): 20,251 @ $15EDGAR
2026-02-274Tango Therapeutics, Inc. (TNGX)Sale (S): 54,345 @ $12.77EDGAR
2026-02-044Tango Therapeutics, Inc. (TNGX)Grant/award (A): 47,460 @ $0 · Sale (S): 18,251 @ $12.26 · Sale (S): 201 @ $12.90 · Grant/award (A): 284,760 (derivative) @ $0EDGAR
2025-02-064Tango Therapeutics, Inc. (TNGX)Sale (S): 7,432 @ $2.99 · Sale (S): 6,851 @ $3.16EDGAR
2025-02-054Tango Therapeutics, Inc. (TNGX)Grant/award (A): 53,015 @ $0 · Grant/award (A): 318,090 (derivative) @ $0EDGAR
2024-02-084Tango Therapeutics, Inc. (TNGX)Sale (S): 4,288 @ $12.56 · Sale (S): 4,083 @ $12.62EDGAR
2024-02-054Tango Therapeutics, Inc. (TNGX)Grant/award (A): 46,599 @ $0 · Grant/award (A): 279,593 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1825445 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →